We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) Succinolin 5% Suxamethonium chloride anhydricum 100mg/2mL Injection, solution
Section 19A approved medicine
(Approval lapsed) Succinolin 5% Suxamethonium chloride anhydricum 100mg/2mL Injection, solution
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Expired
Medicines in short supply/unavailable
ASTRAZENECA SUXAMETHONIUM CHLORIDE 100mg/2mL injection BP ampoule - ARTG 11988
Indication(s)
For the production of skeletal muscle relaxation in anaesthesia. Suited for procedures requiring only brief relaxation such as endotracheal intubation, endoscopic examinations, orthopaedic manipulations, short surgical procedures and electro-convulsive therapy.
Additional information
The s19A product Succinolin contains 10% more suxamethonium than the registered product, AstraZeneca Suxamethonium Chloride - ARTG 11988. The volume injected will therefore need to be adjusted to provide an equivalent dose.